Baylor College of Medicine News

Cancer News

Saving the heart after cancer treatmentFeb 9, 2015
Baylor experts say early screening and monitoring using echocardiograms could be the key to helping cancer survivors stay heart healthy.
Grant allows development of 'freeze-frame' proteins to study DNAJan 30, 2015
Baylor College of Medicine's Dr. Susan Rosenberg and colleagues awarded three-year $2 million grant from W.M. Keck Foundation.
First comprehensive Lung Institute in Texas offers hope along with world class team of experts Jan 16, 2015
Baylor College of Medicine and Baylor St. Luke’s Medical Center have developed the first comprehensive, multi-specialty Lung Institute in the state of Texas.
Grant supports research on potential immunotherapy treatment for neuroblastomaDec 30, 2014

Dr. Leonid Metelitsa, named among inaugural recipients of the Bio-therapeutics Impact Award from Alex’s Lemonade Stand.

Obesity, acid reflux precursors for esophageal cancerDec 29, 2014

New review examines latest developments in the risk factors, pathologies, diagnosis and treatment of esophageal cancers.

Dr. Trey Westbrook named TAMEST 2015 Edith and Peter O’Donnell Award winner in medicine Dec 9, 2014
Baylor College of Medicine researcher Dr. Thomas “Trey” Westbrook tapped for prestigious honor given annually to one scientist across the state of Texas for outstanding innovation in medicine.
New study identifies first gene associated with familial gliomaDec 7, 2014
Baylor-led research identifies for the first time a gene associated with familial glioma, brain tumors that appear in two or more members of the same family.
'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancerDec 3, 2014
A novel mechanism – similar to how normal tissue stem cells respond to wounding – might explain why bladder cancer stem cells actively contribute to chemo-resistance after multiple cycles of chemotherapy drug treatment.
Baylor College of Medicine awarded additional $9.9 million in state cancer funding Nov 20, 2014
Researchers in the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine have been awarded an additional $9.9 million in grant funding from the Cancer Prevention and Research Institute of Texas.
TopBP1 a sweet spot for treatment in multiple cancersNov 17, 2014
A compound called calcein may act to inhibit topoisomerase IIβ-binding protein 1 (TopBP1), which enhances the growth of tumors, said researchers from Baylor College of Medicine.